BRPI1008042A2 - uso de estilbeno hidroxilano na fabricação de uma composição neutracêutica - Google Patents

uso de estilbeno hidroxilano na fabricação de uma composição neutracêutica

Info

Publication number
BRPI1008042A2
BRPI1008042A2 BRPI1008042A BRPI1008042A BRPI1008042A2 BR PI1008042 A2 BRPI1008042 A2 BR PI1008042A2 BR PI1008042 A BRPI1008042 A BR PI1008042A BR PI1008042 A BRPI1008042 A BR PI1008042A BR PI1008042 A2 BRPI1008042 A2 BR PI1008042A2
Authority
BR
Brazil
Prior art keywords
neutraceous
hydroxylan
stilbene
manufacture
composition
Prior art date
Application number
BRPI1008042A
Other languages
English (en)
Inventor
Eline Marleen Van Der Beek
Martine Groenendijk
Mattheus Cornelis De Wilde
Patrick Joseph Gerardus Hendrikus Kamphuis
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BRPI1008042A2 publication Critical patent/BRPI1008042A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/127—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1008042A 2009-02-20 2010-02-19 uso de estilbeno hidroxilano na fabricação de uma composição neutracêutica BRPI1008042A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2009/050078 WO2010095926A1 (en) 2009-02-20 2009-02-20 Use of reveratrol for preserving cognitive functioning
PCT/NL2010/050085 WO2010095943A2 (en) 2009-02-20 2010-02-19 Use of resveratrol or another hydroxylated stilbene for preserving cognitive functioning

Publications (1)

Publication Number Publication Date
BRPI1008042A2 true BRPI1008042A2 (pt) 2016-03-15

Family

ID=40532548

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008042A BRPI1008042A2 (pt) 2009-02-20 2010-02-19 uso de estilbeno hidroxilano na fabricação de uma composição neutracêutica

Country Status (5)

Country Link
US (1) US20120165412A1 (pt)
EP (1) EP2398471A2 (pt)
CN (1) CN102958516A (pt)
BR (1) BRPI1008042A2 (pt)
WO (2) WO2010095926A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2727043T3 (es) * 2011-03-18 2019-10-11 Nestle Sa Composiciones y métodos útiles para mejorar enfermedades relacionadas con la edad
US9439875B2 (en) * 2011-05-11 2016-09-13 The United States Of America, As Represented By The Secretary Of Agriculture Anxiolytic effect of pterostilbene
US8782192B2 (en) 2011-05-31 2014-07-15 Red Hat, Inc. Detecting resource consumption events over sliding intervals in cloud-based network
US20130296441A1 (en) * 2012-05-03 2013-11-07 Agnes Rimando Anti-Obesity Properties of Pterostilbene
JP2014024774A (ja) * 2012-07-25 2014-02-06 Lion Corp 睡眠の質改善剤
CN103865804B (zh) * 2014-01-26 2016-12-07 玉林师范学院 β-葡萄糖苷酶高产菌及其在转化制备白藜芦醇中的应用
US10155003B2 (en) 2014-05-05 2018-12-18 The Board Of Regents Of The University Of Texas System Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
CN104130110B (zh) * 2014-08-12 2015-08-26 四川天予植物药业有限公司 白藜芦醇的提取方法及其获得的白藜芦醇和药物组合物
CN104147027A (zh) * 2014-08-20 2014-11-19 安树君 一种白藜芦醇衍生物的新用途
US10143684B1 (en) * 2014-09-23 2018-12-04 University Of Massachusetts Aberrant sonic hedgehog signaling in neuropsychiatric disorders
CN105582068A (zh) * 2015-12-29 2016-05-18 西南交通大学 熟大黄微粉在制备抗焦虑药物中的用途
CN105687168A (zh) * 2016-01-22 2016-06-22 江苏大学 白藜芦醇在制备抗抑郁药物中的应用
RU2019108100A (ru) 2016-08-22 2020-09-22 Элизиум Хелт, Инк. Композиции никотинамид рибозида и птеростильбена и методы лечения нейродегенеративных заболеваний
WO2018178029A1 (en) * 2017-03-27 2018-10-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating degenerative muscular and/or neurological conditions or diseases
EP3624808A4 (en) * 2017-05-18 2021-03-03 Elysium Health, Inc. PROCEDURES AND COMPOSITIONS FOR IMPROVED SLEEP
US20190038571A1 (en) * 2017-08-07 2019-02-07 Daniel E. Benjamin Orally Available Small Molecules to Inhibit the Function of the Complement System
JP2021500331A (ja) * 2017-10-19 2021-01-07 エリシウム ヘルス，インコーポレーテッド Ｔｄｐ−４３関連疾患の予防及び治療
US10675318B2 (en) * 2018-10-24 2020-06-09 Fu-Hsing Huang Antioxidative activity promoting composition
TWI732147B (zh) * 2018-10-26 2021-07-01 臺北醫學大學 用於抑制乙醯膽鹼酯酶之萃取物及組合物
CN109288852A (zh) * 2018-11-20 2019-02-01 昆药集团股份有限公司 曲札茋苷或其衍生物的用途
WO2020144753A1 (ja) * 2019-01-09 2020-07-16 公立大学法人大阪 神経変性疾患の予防又は治療薬
CN109758438A (zh) * 2019-01-23 2019-05-17 南通大学 银松素的用途及制备方法
CN109730983A (zh) * 2019-03-07 2019-05-10 中国人民解放军陆军特色医学中心 丹叶大黄素在制备治疗脓毒症药物中的应用
WO2021051271A1 (zh) * 2019-09-17 2021-03-25 深圳大学 白皮杉醇在制备预防和治疗神经退行性疾病的药物方面的应用
CN116270576A (zh) * 2020-07-24 2023-06-23 中国医学科学院医药生物技术研究所 多取代苯类化合物在制备认知障碍性疾病的药物中的用途及结构和制备方法
CN112830947B (zh) * 2020-12-21 2022-10-04 中国医学科学院药用植物研究所 拉萨大黄中分离的二苯乙烯类化合物及其在治疗神经系统疾病中的用途
CN112870184A (zh) * 2021-04-21 2021-06-01 澳门大学 丹叶大黄素在制备用于治疗或改善神经退行性疾病的药物中的应用
WO2023150072A1 (en) 2022-02-01 2023-08-10 Sinclair David A Compositions and methods for the preservation of plant matter

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766176B1 (fr) * 1997-07-15 1999-10-29 Caudalie Compositions a base de derives de resveratrol
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
CN1159015C (zh) * 2001-10-30 2004-07-28 首都医科大学宣武医院 二苯乙烯甙在治疗痴呆症中的用途
NL1019368C2 (nl) 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
NZ546785A (en) 2003-10-24 2009-07-31 Nutricia Nv Immunemodulating oligosaccharides
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
US20120016037A1 (en) * 2006-07-24 2012-01-19 Frank Toppo Method for prevention and treatment of Alzheimers
WO2008120220A1 (en) * 2007-04-03 2008-10-09 Ganga Raju Gokaraju Synergistic anti-inflammatory and antioxidant dietary supplement compositions

Also Published As

Publication number Publication date
WO2010095943A3 (en) 2010-11-04
CN102958516A (zh) 2013-03-06
WO2010095926A1 (en) 2010-08-26
US20120165412A1 (en) 2012-06-28
EP2398471A2 (en) 2011-12-28
WO2010095943A2 (en) 2010-08-26

Similar Documents

Publication Publication Date Title
BRPI1008042A2 (pt) uso de estilbeno hidroxilano na fabricação de uma composição neutracêutica
BRPI0821165A2 (pt) Uso de uma composição
SMT201600307B (it) Composizione liposomiale
BRPI1013421A2 (pt) composição parasticida tópica, e, uso de uma composição
BRPI1014316A2 (pt) composição, e, uso de uma composição
BRPI1013335A2 (pt) composição compósita
BRPI1013588A2 (pt) composição
BRPI0912161A2 (pt) composição farmacêutica na forma de um tablete
EP2167602A4 (en) COMPOSITIONS CONTAINING DIFLUOROMETHANE
DE602008002756D1 (de) Bauzusammensetzung
FI20095251L (fi) Uudet materiaalit
BR112012014028A2 (pt) uso de uma composição
BRPI1015474A2 (pt) composição
EP2110390A4 (en) POLYMERIZABLE COMPOSITION
DOP2011000396A (es) Composiciones novedosas
BRPI1005931A2 (pt) associação de compostos, uso de uma associação, produto em forma de kit, uso de um produto e composição farmacêutica
PT2493487T (pt) Composição para induzir uma tolerância imunitária específica
KR102013152B9 (ko) 신규 수지 및 이를 포함하는 포토레지스트 조성물
BRPI1008215A2 (pt) "composição azeotrópica"
EP2500932A4 (en) ADHESIVE COMPOSITION
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BRPI0915127A2 (pt) composição polimerizável
DK2553004T3 (da) Sammensatte materialer
BRPI0925002A2 (pt) uso de uma composição para a prevenção de diarréia
CO6801753A2 (es) Composiciones que contienen cationes de polihidroxioxoaluminio y fabricación de los mismos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/05 (2006.01), A23L 2/52 (2006.01), A23L 33